Following the dramatic late-night resignation of Peter Marks last Friday, Steele, a senior advisor to the division, takes the ...
The U.S. Food and Drug Administration said on Tuesday it had named Scott Steele as acting director of its Center for ...
Amid a dramatic reshaping of the federal healthcare apparatus, the FDA has named an acting leader of its Center for Biologics Evaluation and Research. | Amid a dramatic reshaping of the federal ...
2don MSN
The FDA has delayed granting full approval of Novavax's COVID-19 vaccine despite it being on track to be cleared until ...
The FDA saw a significant reduction in force Tuesday, and former FDA Commissioner Robert Califf said the industry is going to ...
(Reuters) -The U.S. Food and Drug Administration said on Tuesday that it had named Scott Steele as acting director of its Center for Biologics Evaluation and Research, replacing Peter Marks.
(Reuters) - The U.S. Food and Drug Administration said on Tuesday it had named Scott Steele as acting director of its Center for Biologics Evaluation and Research (CBER), following the exit of top ...
US FDA Insider Steele Replaces Marks as Top Vaccine Official, for Now (Reuters) - The U.S. Food and Drug Administration said on Tuesday it had named Scott Steele as acting director of its Center ...
Scott Steele, Ph.D., has been appointed as the acting director of the FDA's Center for Biologics Evaluation and Research. This significant move is expected to bring fresh perspectives to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback